- Home
- DARE vs GAME Comparison
DARE vs GAME Comparison
Compare DARE & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- GAME
- Stock Information
- Founded
- DARE 2015
- GAME 2011
- Country
- DARE United States
- GAME United States
- Employees
- DARE N/A
- GAME N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- GAME
- Sector
- DARE Health Care
- GAME
- Exchange
- DARE Nasdaq
- GAME Nasdaq
- Market Cap
- DARE 26.3M
- GAME 27.2M
- IPO Year
- DARE N/A
- GAME 2009
- Fundamental
- Price
- DARE $3.09
- GAME $1.66
- Analyst Decision
- DARE Strong Buy
- GAME Strong Buy
- Analyst Count
- DARE 3
- GAME 3
- Target Price
- DARE $12.50
- GAME $3.67
- AVG Volume (30 Days)
- DARE 3.9M
- GAME 8.2M
- Earning Date
- DARE 08-11-2025
- GAME 08-13-2025
- Dividend Yield
- DARE N/A
- GAME N/A
- EPS Growth
- DARE N/A
- GAME N/A
- EPS
- DARE N/A
- GAME N/A
- Revenue
- DARE $25,909.00
- GAME $99,579,536.00
- Revenue This Year
- DARE $99,756.91
- GAME $6.08
- Revenue Next Year
- DARE $119.77
- GAME $21.94
- P/E Ratio
- DARE N/A
- GAME N/A
- Revenue Growth
- DARE N/A
- GAME 77.06
- 52 Week Low
- DARE $2.11
- GAME $0.50
- 52 Week High
- DARE $9.19
- GAME $2.87
- Technical
- Relative Strength Index (RSI)
- DARE 66.25
- GAME 66.62
- Support Level
- DARE $2.11
- GAME $1.67
- Resistance Level
- DARE $2.54
- GAME $2.20
- Average True Range (ATR)
- DARE 0.57
- GAME 0.27
- MACD
- DARE 0.04
- GAME 0.11
- Stochastic Oscillator
- DARE 13.84
- GAME 43.64
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.